145 related articles for article (PubMed ID: 9645475)
1. A synthetic human Agouti-related protein-(83-132)-NH2 fragment is a potent inhibitor of melanocortin receptor function.
Quillan JM; Sadée W; Wei ET; Jimenez C; Ji L; Chang JK
FEBS Lett; 1998 May; 428(1-2):59-62. PubMed ID: 9645475
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of melanocortin receptor signaling mediated by the amino terminus of Agouti protein in Xenopus melanophores.
Ollmann MM; Barsh GS
J Biol Chem; 1999 May; 274(22):15837-46. PubMed ID: 10336487
[TBL] [Abstract][Full Text] [Related]
3. Characterization of Agouti-related protein binding to melanocortin receptors.
Yang YK; Thompson DA; Dickinson CJ; Wilken J; Barsh GS; Kent SB; Gantz I
Mol Endocrinol; 1999 Jan; 13(1):148-55. PubMed ID: 9892020
[TBL] [Abstract][Full Text] [Related]
4. Structure activity studies of the melanocortin-4 receptor by in vitro mutagenesis: identification of agouti-related protein (AGRP), melanocortin agonist and synthetic peptide antagonist interaction determinants.
Haskell-Luevano C; Cone RD; Monck EK; Wan YP
Biochemistry; 2001 May; 40(20):6164-79. PubMed ID: 11352754
[TBL] [Abstract][Full Text] [Related]
5. Novel agouti-related-protein-based melanocortin-1 receptor antagonist.
Thirumoorthy R; Holder JR; Bauzo RM; Richards NG; Edison AS; Haskell-Luevano C
J Med Chem; 2001 Nov; 44(24):4114-24. PubMed ID: 11708914
[TBL] [Abstract][Full Text] [Related]
6. Molecular interaction of Agouti protein and Agouti-related protein with human melanocortin receptors.
Tota MR; Smith TS; Mao C; MacNeil T; Mosley RT; Van der Ploeg LH; Fong TM
Biochemistry; 1999 Jan; 38(3):897-904. PubMed ID: 9893984
[TBL] [Abstract][Full Text] [Related]
7. Antagonist and agonist activities of the mouse agouti protein fragment (91-131) at the melanocortin-1 receptor.
Eberle AN; Bódi J; Orosz G; Süli-Vargha H; Jäggin V; Zumsteg U
J Recept Signal Transduct Res; 2001 Feb; 21(1):25-45. PubMed ID: 11693171
[TBL] [Abstract][Full Text] [Related]
8. Melanocortin receptor binding determinants in the agouti protein.
Kiefer LL; Veal JM; Mountjoy KG; Wilkison WO
Biochemistry; 1998 Jan; 37(4):991-7. PubMed ID: 9454589
[TBL] [Abstract][Full Text] [Related]
9. Molecular determination of agouti-related protein binding to human melanocortin-4 receptor.
Yang Y; Chen M; Lai Y; Gantz I; Yagmurlu A; Georgeson KE; Harmon CM
Mol Pharmacol; 2003 Jul; 64(1):94-103. PubMed ID: 12815165
[TBL] [Abstract][Full Text] [Related]
10. A C-terminal fragment of Agouti-related protein increases feeding and antagonizes the effect of alpha-melanocyte stimulating hormone in vivo.
Rossi M; Kim MS; Morgan DG; Small CJ; Edwards CM; Sunter D; Abusnana S; Goldstone AP; Russell SH; Stanley SA; Smith DM; Yagaloff K; Ghatei MA; Bloom SR
Endocrinology; 1998 Oct; 139(10):4428-31. PubMed ID: 9751529
[TBL] [Abstract][Full Text] [Related]
11. Biochemical, biophysical, and pharmacological characterization of bacterially expressed human agouti-related protein.
Rosenfeld RD; Zeni L; Welcher AA; Narhi LO; Hale C; Marasco J; Delaney J; Gleason T; Philo JS; Katta V; Hui J; Baumgartner J; Graham M; Stark KL; Karbon W
Biochemistry; 1998 Nov; 37(46):16041-52. PubMed ID: 9819197
[TBL] [Abstract][Full Text] [Related]
12. Receptor-antagonist interactions in the complexes of agouti and agouti-related protein with human melanocortin 1 and 4 receptors.
Chai BX; Pogozheva ID; Lai YM; Li JY; Neubig RR; Mosberg HI; Gantz I
Biochemistry; 2005 Mar; 44(9):3418-31. PubMed ID: 15736952
[TBL] [Abstract][Full Text] [Related]
13. Contribution of melanocortin receptor exoloops to Agouti-related protein binding.
Yang YK; Dickinson CJ; Zeng Q; Li JY; Thompson DA; Gantz I
J Biol Chem; 1999 May; 274(20):14100-6. PubMed ID: 10318826
[TBL] [Abstract][Full Text] [Related]
14. Interaction of Agouti protein with the melanocortin 1 receptor in vitro and in vivo.
Ollmann MM; Lamoreux ML; Wilson BD; Barsh GS
Genes Dev; 1998 Feb; 12(3):316-30. PubMed ID: 9450927
[TBL] [Abstract][Full Text] [Related]
15. High-resolution NMR structure of the chemically-synthesized melanocortin receptor binding domain AGRP(87-132) of the agouti-related protein.
McNulty JC; Thompson DA; Bolin KA; Wilken J; Barsh GS; Millhauser GL
Biochemistry; 2001 Dec; 40(51):15520-7. PubMed ID: 11747427
[TBL] [Abstract][Full Text] [Related]
16. NMR structure of a minimized human agouti related protein prepared by total chemical synthesis.
Bolin KA; Anderson DJ; Trulson JA; Thompson DA; Wilken J; Kent SB; Gantz I; Millhauser GL
FEBS Lett; 1999 May; 451(2):125-31. PubMed ID: 10371151
[TBL] [Abstract][Full Text] [Related]
17. Design, pharmacology, and NMR structure of a minimized cystine knot with agouti-related protein activity.
Jackson PJ; McNulty JC; Yang YK; Thompson DA; Chai B; Gantz I; Barsh GS; Millhauser GL
Biochemistry; 2002 Jun; 41(24):7565-72. PubMed ID: 12056887
[TBL] [Abstract][Full Text] [Related]
18. Structural characterization and pharmacology of a potent (Cys101-Cys119, Cys110-Cys117) bicyclic agouti-related protein (AGRP) melanocortin receptor antagonist.
Wilczynski A; Wang XS; Bauzo RM; Xiang Z; Shaw AM; Millard WJ; Richards NG; Edison AS; Haskell-Luevano C
J Med Chem; 2004 Nov; 47(23):5662-73. PubMed ID: 15509165
[TBL] [Abstract][Full Text] [Related]
19. Agouti antagonism of melanocortin-4 receptor: greater effect with desacetyl-alpha-melanocyte-stimulating hormone (MSH) than with alpha-MSH.
Mountjoy KG; Willard DH; Wilkison WO
Endocrinology; 1999 May; 140(5):2167-72. PubMed ID: 10218968
[TBL] [Abstract][Full Text] [Related]
20. The agouti-related protein decapeptide (Yc[CRFFNAFC]Y) possesses agonist activity at the murine melanocortin-1 receptor.
Haskell-Luevano C; Monck EK; Wan YP; Schentrup AM
Peptides; 2000 May; 21(5):683-9. PubMed ID: 10876051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
